Literature DB >> 7896614

Hypoxic inhibition of breathing in fetal sheep: relationship to brain adenosine concentrations.

B J Koos1, B A Mason, O Punla, A M Adinolfi.   

Abstract

Because hypoxic inhibition of fetal breathing may be caused by a rise in central adenosine levels, the effects of O2 deficiency on fetal brain adenosine concentrations were determined at levels of hypoxia that inhibited fetal breathing. Under halothane anesthesia, the brains of fetal sheep (0.8 term) were implanted with guide cannulas exteriorized through a Silastic rubber window in the uterus and flank of the ewe. At least 4 days after surgery, a microdialysis probe was inserted into a cannula with the membrane tip placed in the rostral brain stem. During 1 h of isocapnic hypoxia, mean fetal arterial PO2 was reduced from 24.0 +/- 0.9 Torr (control) to 13 +/- 0.6 Torr and arterial pH fell progressively from 7.354 +/- 0.007 to 7.273 +/- 0.023. Hypoxia decreased the incidence of fetal breathing movements from 33 +/- 5.2 to 5 +/- 2.2 min/h, with a normal incidence (29 +/- 3.5 min/h) during the hour after arterial PO2 returned to control values. Adenosine concentrations in microdialysis perfusate under control conditions averaged approximately 35 nM, increased up to 2.3-fold during the hour of O2 deficiency, and fell toward control values when normoxia was restored. We conclude that fetal brain adenosine levels are increased at levels of O2 deficiency that inhibit fetal breathing, which are results consistent with a role for adenosine in hypoxic inhibition of fetal breathing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7896614     DOI: 10.1152/jappl.1994.77.6.2734

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  9 in total

Review 1.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 2.  The role of CO(2) and central chemoreception in the control of breathing in the fetus and the neonate.

Authors:  Robert A Darnall
Journal:  Respir Physiol Neurobiol       Date:  2010-04-23       Impact factor: 1.931

3.  The role of adenosine in regulation of cerebral blood flow during hypoxia in the near-term fetal sheep.

Authors:  Arlin B Blood; Christian J Hunter; Gordon G Power
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

4.  Adenosine mediates decreased cerebral metabolic rate and increased cerebral blood flow during acute moderate hypoxia in the near-term fetal sheep.

Authors:  Arlin B Blood; Christian J Hunter; Gordon G Power
Journal:  J Physiol       Date:  2003-09-18       Impact factor: 5.182

5.  Embryonic caffeine exposure induces adverse effects in adulthood.

Authors:  Christopher C Wendler; Melissa Busovsky-McNeal; Satish Ghatpande; April Kalinowski; Kerry S Russell; Scott A Rivkees
Journal:  FASEB J       Date:  2008-12-16       Impact factor: 5.191

6.  Adenosine mediates metabolic and cardiovascular responses to hypoxia in fetal sheep.

Authors:  B J Koos; A Chau; D Ogunyemi
Journal:  J Physiol       Date:  1995-11-01       Impact factor: 5.182

7.  Adenosine A1 and A2a receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep.

Authors:  Takatsugu Maeda; Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-31       Impact factor: 3.619

8.  Increased Prostaglandin E2 in Brainstem Respiratory Centers Is Associated With Inhibition of Breathing Movements in Fetal Sheep Exposed to Progressive Systemic Inflammation.

Authors:  Vanesa Stojanovska; John Atta; Sharmony B Kelly; Valerie A Zahra; Eva Matthews-Staindl; Ilias Nitsos; Alison Moxham; Yen Pham; Stuart B Hooper; Eric Herlenius; Robert Galinsky; Graeme R Polglase
Journal:  Front Physiol       Date:  2022-03-03       Impact factor: 4.566

9.  Perinatal Hypoxemia and Oxygen Sensing.

Authors:  Gary C Mouradian; Satyan Lakshminrusimha; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.